Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Classifica tra le azioni #37
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Prezzo delle azioni
$419.17
Capitalizzazione di mercato
$333.66B
Variazione (1 giorno)
0.50%
Variazione (1 anno)
14.13%
Paese
CH
Scambia Roche Holding AG (ROG)

Categoria

Ricavi di Roche Holding AG (ROG)
Ricavi nel Dec 2025 TTM: $77.52B
Secondo gli ultimi rapporti finanziari di Roche Holding AG, i ricavi attuali dell'azienda (TTM) sono pari a $77.52B. Nel 2024, l'azienda ha registrato ricavi di $69.07B una diminuzione rispetto a i ricavi dell'anno 2023, che erano pari a $71.87B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Roche Holding AG da 2000 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $77.52B 0.00%
2025 $77.52B 12.23%
2024 $69.07B -3.89%
2023 $71.87B 0.96%
2022 $71.19B 3.34%
2021 $68.88B 6.09%
2020 $64.93B -1.48%
2019 $65.90B 8.96%
2018 $60.48B 5.74%
2017 $57.20B 10.60%
2016 $51.72B 2.56%
2015 $50.42B 0.45%
2014 $50.20B -7.86%
2013 $54.48B 9.59%
2012 $49.71B 9.80%
2011 $45.28B -10.87%
2010 $50.80B 7.01%
2009 $47.47B 11.15%
2008 $42.71B 4.63%
2007 $40.82B 18.37%
2006 $34.48B 27.80%
2005 $26.98B -1.91%
2004 $27.51B 8.99%
2003 $25.24B 17.44%
2002 $21.49B 22.59%
2001 $17.53B -0.62%
2000 $17.64B 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese